Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 02-Oct-24 4:58 PM View:  | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 01-Oct-24 | Private Sale (Planned) | 2,000 | $83.83 | $167,660.00 | (2%) 102.19K to 100.19K | |
| 13-Sep-24 7:07 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 12-Sep-24 | Option Exercise | 25,000 | $57.92 | $1,448,000.00 | 25% 98.44K to 123.44K | |
| 13-Sep-24 5:08 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 12-Sep-24 | Private Sale (Planned) | 29,357 | $83.78 | $2,459,580.00 | (27%) 107.48K to 78.13K | |
| 13-Sep-24 7:07 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 12-Sep-24 | Planned Option Sale | 21,246 | $84.50 | $1,795,290.00 | (17%) 123.44K to 102.19K | |
| 11-Sep-24 7:33 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Option Exercise | 3,821 | -- | -- | 4% 96.38K to 100.2K | |
| 11-Sep-24 7:41 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Payment of Exercise | 307 | $81.44 | $25,002.10 | (1%) 21.01K to 20.71K | |
| 11-Sep-24 7:20 PM View: | Dickinson Andrew D Chief Financial Officer | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Option Exercise | 3,641 | -- | -- | 3% 136.96K to 140.6K | |
| 11-Sep-24 7:38 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Payment of Exercise | 292 | $81.44 | $23,780.50 | (< 1%) 36.88K to 36.59K | |
| 11-Sep-24 7:23 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Payment of Exercise | 1,734 | $81.44 | $141,217.00 | (2%) 109.22K to 107.48K | |
| 11-Sep-24 7:41 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Option Exercise | 639 | -- | -- | 3% 20.38K to 21.01K | |
| 11-Sep-24 7:30 PM View: | O'Day Daniel Patrick Chairman & CEO Director | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Payment of Exercise | 4,749 | $81.44 | $386,759.00 | (< 1%) 500.74K to 496.0K | |
| 11-Sep-24 7:38 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Option Exercise | 901 | -- | -- | 3% 35.98K to 36.88K | |
| 11-Sep-24 7:33 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Payment of Exercise | 1,766 | $81.44 | $143,823.00 | (2%) 100.2K to 98.44K | |
| 11-Sep-24 7:23 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Option Exercise | 3,752 | -- | -- | 4% 105.47K to 109.22K | |
| 11-Sep-24 7:20 PM View: | Dickinson Andrew D Chief Financial Officer | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Payment of Exercise | 1,682 | $81.44 | $136,982.00 | (1%) 140.6K to 138.92K | |
| 11-Sep-24 7:30 PM View: | O'Day Daniel Patrick Chairman & CEO Director | Gilead Sciences Inc. (GILD) | 10-Sep-24 | Option Exercise | 10,295 | -- | -- | 2% 490.45K to 500.74K | |
| 29-Aug-24 3:23 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 28-Aug-24 | Private Sale (Planned) | 9,513 | $78.03 | $742,299.00 | (8%) 114.98K to 105.47K | |
| 14-Aug-24 2:23 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 13-Aug-24 | Market Sale (Planned) | 5,490 | $73.98 | $406,150.00 | (5%) 120.47K to 114.98K | 3% |
| 12-Aug-24 4:22 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Aug-24 | Payment of Exercise | 980 | $73.66 | $72,186.80 | (3%) 36.96K to 35.98K | |
| 12-Aug-24 4:22 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Aug-24 | Option Exercise | 3,678 | -- | -- | 11% 33.28K to 36.96K | |
| 26-Jul-24 5:28 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 25-Jul-24 | Payment of Exercise | 2,917 | $76.51 | $223,180.00 | (13%) 23.29K to 20.38K | |
| 26-Jul-24 5:28 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 25-Jul-24 | Option Exercise | 8,744 | -- | -- | 60% 14.55K to 23.29K | |
| 01-Jul-24 8:06 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 01-Jul-24 | Market Sale (Planned) | 2,000 | $68.63 | $137,260.00 | (2%) 98.38K to 96.38K | (5%) |
| 11-Jun-24 7:25 PM View: | Dickinson Andrew D Chief Financial Officer | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Payment of Exercise | 1,662 | $65.25 | $108,446.00 | (1%) 138.62K to 136.96K | |
| 11-Jun-24 7:20 PM View: | O'Day Daniel Patrick Chairman & CEO Director | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Option Exercise | 10,295 | -- | -- | 2% 484.85K to 495.14K | |
| 11-Jun-24 7:18 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Payment of Exercise | 1,714 | $65.25 | $111,838.00 | (1%) 122.18K to 120.47K | |
| 11-Jun-24 7:12 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Option Exercise | 638 | -- | -- | 5% 14.11K to 14.75K | |
| 11-Jun-24 7:25 PM View: | Dickinson Andrew D Chief Financial Officer | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Option Exercise | 3,639 | -- | -- | 3% 134.98K to 138.62K | |
| 11-Jun-24 7:23 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Option Exercise | 901 | -- | -- | 3% 32.63K to 33.53K | |
| 11-Jun-24 7:15 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Payment of Exercise | 1,744 | $65.25 | $113,796.00 | (2%) 100.12K to 98.38K | |
| 11-Jun-24 7:12 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Payment of Exercise | 204 | $65.25 | $13,311.00 | (1%) 14.75K to 14.55K | |
| 11-Jun-24 7:18 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Option Exercise | 3,751 | -- | -- | 3% 118.43K to 122.18K | |
| 11-Jun-24 7:23 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Payment of Exercise | 255 | $65.25 | $16,638.80 | (< 1%) 33.53K to 33.28K | |
| 11-Jun-24 7:20 PM View: | O'Day Daniel Patrick Chairman & CEO Director | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Payment of Exercise | 4,693 | $65.25 | $306,218.00 | (< 1%) 495.14K to 490.45K | |
| 11-Jun-24 7:15 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 10-Jun-24 | Option Exercise | 3,820 | -- | -- | 4% 96.3K to 100.12K | |
| 09-May-24 5:57 PM View: | Barton Jacqueline K Director | Gilead Sciences Inc. (GILD) | 08-May-24 | Grant | 2,310 | -- | -- | 10% 22.23K to 24.54K | |
| 09-May-24 5:30 PM View: | Love Ted W Director | Gilead Sciences Inc. (GILD) | 08-May-24 | Grant | 2,310 | -- | -- | 451% 0.51K to 2.82K | |
| 09-May-24 5:23 PM View: | Welters Anthony Director | Gilead Sciences Inc. (GILD) | 08-May-24 | Grant | 2,310 | -- | -- | 29% 7.92K to 10.23K | |
| 09-May-24 5:26 PM View: | Rodriguez Javier Director | Gilead Sciences Inc. (GILD) | 08-May-24 | Grant | 2,310 | -- | -- | 28% 8.39K to 10.7K | |
| 09-May-24 5:16 PM View: | Manwani Harish Director | Gilead Sciences Inc. (GILD) | 08-May-24 | Grant | 2,310 | -- | -- | 21% 11.01K to 13.32K | |
| 09-May-24 5:16 PM View: | Manwani Harish Director | Gilead Sciences Inc. (GILD) | 08-May-24 | Payment of Exercise | 451 | $64.92 | $29,278.90 | (3%) 13.32K to 12.87K | |
| 26-Apr-24 4:30 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 25-Apr-24 | Payment of Exercise | 158 | $65.27 | $10,312.70 | (1%) 14.27K to 14.11K | |
| 26-Apr-24 4:30 PM View: | Telman Deborah H EVP, Corporate Affairs & GC | Gilead Sciences Inc. (GILD) | 25-Apr-24 | Option Exercise | 515 | -- | -- | 4% 13.76K to 14.27K | |
| 02-Apr-24 6:38 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 01-Apr-24 | Market Sale (Planned) | 2,000 | $72.96 | $145,920.00 | (2%) 98.3K to 96.3K | 1% |
| 11-Mar-24 9:14 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 10-Mar-24 | Option Exercise | 10,401 | -- | -- | 11% 92.71K to 103.11K | |
| 11-Mar-24 8:59 PM View: | Dickinson Andrew D Chief Financial Officer | Gilead Sciences Inc. (GILD) | 10-Mar-24 | Option Exercise | 9,732 | -- | -- | 8% 129.76K to 139.49K | |
| 12-Mar-24 3:57 PM View: | Patterson Sandra SVP, Controllership | Gilead Sciences Inc. (GILD) | 10-Mar-24 | Option Exercise | 2,682 | -- | -- | 9% 30.74K to 33.42K | |
| 11-Mar-24 9:11 PM View: | O'Day Daniel Patrick Chairman & CEO Director | Gilead Sciences Inc. (GILD) | 10-Mar-24 | Option Exercise | 29,940 | -- | -- | 6% 468.69K to 498.63K | |
| 11-Mar-24 9:14 PM View: | Parsey Merdad Chief Medical Officer | Gilead Sciences Inc. (GILD) | 10-Mar-24 | Payment of Exercise | 4,803 | $75.12 | $360,801.00 | (5%) 103.11K to 98.3K | |
| 11-Mar-24 9:03 PM View: | Mercier Johanna Chief Commercial Officer | Gilead Sciences Inc. (GILD) | 10-Mar-24 | Option Exercise | 9,844 | -- | -- | 9% 113.15K to 122.99K |
